Kohjin Bio Co (TSE:177A) Gross Margin %: 34.69% (As of Mar. 2026) — 24% Below Median


TSE:177A Kohjin Bio Co Ltd TSE:177A
17 GF Score
Price 円866.00
! 3 Warning Signs
View Full Analysis

What is Kohjin Bio Co Gross Margin %?

Kohjin Bio Co TSE:177A +0.12% 17 Gross Margin % is 34.69% as of Mar. 2026, which is 24% below its 10-year median of 45.45. GuruFocus rates TSE:177A with a GF Score™ of 17/100. The stock has 3 warning signs investors should review. Among 730 Biotechnology companies, Kohjin Bio Co ranks worse than 71.1% on this metric.

Gross Margin % is calculated as gross profit divided by its revenue. Kohjin Bio Co's Gross Profit for the six months ended in Mar. 2026 was 円845 Mil. Kohjin Bio Co's Revenue for the six months ended in Mar. 2026 was 円2,435 Mil. Therefore, Kohjin Bio Co's Gross Margin % for the quarter that ended in Mar. 2026 was 34.69%.


The historical rank and industry rank for Kohjin Bio Co's Gross Margin % or its related term are showing as below:

TSE:177A' s Gross Margin % Range Over the Past 10 Years
Min: 37.6   Med: 45.45   Max: 51.74
Current: 37.6


During the past 5 years, the highest Gross Margin % of Kohjin Bio Co was 51.74%. The lowest was 37.60%. And the median was 45.45%.

TSE:177A's Gross Margin % is ranked worse than
71.1% of 730 companies
in the Biotechnology industry
Industry Median: 60.91 vs TSE:177A: 37.60

Kohjin Bio Co had a gross margin of 34.69% for the quarter that ended in Mar. 2026 => Competition eroding margins

The 5-Year average Growth Rate of Gross Margin for Kohjin Bio Co was 0.00% per year.


Kohjin Bio Co  (TSE:177A) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Kohjin Bio Co had a gross margin of 34.69% for the quarter that ended in Mar. 2026 => Competition eroding margins


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Kohjin Bio Co Gross Margin % Related Terms


Kohjin Bio Co Gross Margin % Historical Data

* Premium members only.

The historical data trend for Kohjin Bio Co's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kohjin Bio Co Gross Margin % Chart

Kohjin Bio Co Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
Gross Margin %
51.66 51.74 39.44 45.45 37.60

Kohjin Bio Co Semi-Annual Data
Mar22 Mar23 Mar24 Sep24 Mar25 Sep25 Mar26
Gross Margin % Get a 7-Day Free Trial 0.00 42.23 48.43 40.43 34.69

TSE:177A vs VRTX, REGN, ALNY: Gross Margin % Comparison

For the Biotechnology subindustry, Kohjin Bio Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kohjin Bio Co Gross Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Kohjin Bio Co's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Kohjin Bio Co's Gross Margin % falls into.


TSE:177A
17GF Score
Kohjin Bio Co Ltd TSE:177A
Gross Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kohjin Bio Co Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Kohjin Bio Co's Gross Margin for the fiscal year that ended in Mar. 2026 is calculated as

Gross Margin % (A: Mar. 2026 )=Gross Profit (A: Mar. 2026 ) / Revenue (A: Mar. 2026 )
=1857.2 / 4939.025
=(Revenue - Cost of Goods Sold) / Revenue
=(4939.025 - 3081.794) / 4939.025
=37.60 %

Kohjin Bio Co's Gross Margin for the quarter that ended in Mar. 2026 is calculated as


Gross Margin % (Q: Mar. 2026 )=Gross Profit (Q: Mar. 2026 ) / Revenue (Q: Mar. 2026 )
=844.6 / 2434.545
=(Revenue - Cost of Goods Sold) / Revenue
=(2434.545 - 1589.934) / 2434.545
=34.69 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Frequently Asked Questions Learn more about Gross Margin % →
What does a Gross Margin % of 34.69% mean?
Kohjin Bio Co (TSE:177A) has a Gross Margin % of 34.69% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Kohjin Bio Co and its competitors. This is 24% below median its historical median of 45.45. Over the past decade, Kohjin Bio Co's Gross Margin % has ranged from 37.60 to 51.74. According to the industry distribution chart, Kohjin Bio Co ranks #519 out of 730 companies in the Biotechnology industry, placing it in the top 71.1%.
Is Kohjin Bio Co's Gross Margin % too high?
Kohjin Bio Co's current Gross Margin % of 34.69% is 24% below median its 10-year median of 45.45. Over the past 10 years, this metric has ranged from a low of 37.60 to a high of 51.74. The Biotechnology industry median Gross Margin % is 60.91. Kohjin Bio Co's value of 34.69% is 43% below this industry median. Based on the distribution chart, Kohjin Bio Co ranks #519 out of 730 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Kohjin Bio Co has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Kohjin Bio Co's Gross Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Kohjin Bio Co ranks #519 out of 730 companies for Gross Margin %. This places Kohjin Bio Co in the lower half of its industry. The industry median Gross Margin % is 60.91. Kohjin Bio Co's value of 34.69% is 43% below this benchmark. Historically, Kohjin Bio Co's own Gross Margin % has ranged from 37.60 to 51.74 over the past decade. While the company's 10-year median is 45.45 vs. the industry median of 60.91, Kohjin Bio Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Biotechnology company?
The median Gross Margin % among Biotechnology companies is 60.91, based on 730 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kohjin Bio Co's current Gross Margin % of 34.69% is 43% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Kohjin Bio Co and its competitors. For the Biotechnology industry, the median Gross Margin % is 60.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kohjin Bio Co's current Gross Margin % is 34.69%, which is 24% below median its own 10-year median of 45.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kohjin Bio Co stock overvalued right now?
Kohjin Bio Co (TSE:177A) has a current Gross Margin % of 34.69%. The current Gross Margin % is 34.69%, which is 24% below median its 10-year median of 45.45 and 43% below the Biotechnology industry median of 60.91. Kohjin Bio Co's overall GF Score™ is 17/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Kohjin Bio Co (TSE:177A), the current Gross Margin % is 34.69% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kohjin Bio Co Business Description

Address 5-1-3 Chiyoda, Sakado, Saitama, JPN, 350-0214
Kohjin Bio Co Ltd is engaged in development, manufacture and sale of culture media (growing environments used for culturing microorganisms and cells) and contract manufacturing of processed cell products. It has manufacturing and sales of animal blood, sera, tissue culture media, media for microbiology testing, in vitro diagnostic agents, and cosmetics.
17GF Score

Get the complete analysis for TSE:177A

Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円866.00
Price